Cargando…
Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis
BACKGROUND: The indication for prescribing a particular medication, or its reason for use (RFU) is a crucial piece of information for all those involved in the circle of care. Research has shown that sharing RFU information with physicians, pharmacists and patients improves patient safety and patien...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836591/ https://www.ncbi.nlm.nih.gov/pubmed/33499869 http://dx.doi.org/10.1186/s12913-021-06103-1 |
_version_ | 1783642782307450880 |
---|---|
author | Whaley, Colin Bancsi, Ashley Ho, Joanne Man-Wai Burns, Catherine M. Grindrod, Kelly |
author_facet | Whaley, Colin Bancsi, Ashley Ho, Joanne Man-Wai Burns, Catherine M. Grindrod, Kelly |
author_sort | Whaley, Colin |
collection | PubMed |
description | BACKGROUND: The indication for prescribing a particular medication, or its reason for use (RFU) is a crucial piece of information for all those involved in the circle of care. Research has shown that sharing RFU information with physicians, pharmacists and patients improves patient safety and patient adherence, however RFU is rarely added on prescriptions by prescribers or on medication labels for patients to reference. METHODS: Qualitative interviews were conducted with 20 prescribers in Southern Ontario, Canada, to learn prescribers’ current attitudes on the addition of RFU on prescriptions and medication labels. A trained interviewer used a semi-structured interview guide for each interview. The interviews explored how the sharing of RFU information would impact prescribers’ workflows and practices. Interviews were recorded, transcribed and thematically coded. RESULTS: The analysis yielded four main themes: Current Practice, Future Practice, Changing Culture, and Collaboration. Most of the prescribers interviewed do not currently add RFU to prescriptions. Prescribers were open to sharing RFU with colleagues via a regional database but wanted the ability to provide context for the prescribed medication within the system. Many prescribers were wary of the impact of adding RFU on their workflow but felt it could save time by avoiding clarifying questions from pharmacists. Increased interprofessional collaboration, increased patient understanding of prescribed medications, avoiding guesswork when determining indications and decreased misinterpretation regarding RFU were cited by most prescribers as benefits to including RFU information. CONCLUSIONS: Prescribers were generally open to sharing RFU and clearly identified the benefits to pharmacists and patients if added. Critically, they also identified benefits to their own practices. These results can be used to guide the implementation of future initiatives to promote the sharing of RFU in healthcare teams. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-021-06103-1. |
format | Online Article Text |
id | pubmed-7836591 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78365912021-01-27 Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis Whaley, Colin Bancsi, Ashley Ho, Joanne Man-Wai Burns, Catherine M. Grindrod, Kelly BMC Health Serv Res Research Article BACKGROUND: The indication for prescribing a particular medication, or its reason for use (RFU) is a crucial piece of information for all those involved in the circle of care. Research has shown that sharing RFU information with physicians, pharmacists and patients improves patient safety and patient adherence, however RFU is rarely added on prescriptions by prescribers or on medication labels for patients to reference. METHODS: Qualitative interviews were conducted with 20 prescribers in Southern Ontario, Canada, to learn prescribers’ current attitudes on the addition of RFU on prescriptions and medication labels. A trained interviewer used a semi-structured interview guide for each interview. The interviews explored how the sharing of RFU information would impact prescribers’ workflows and practices. Interviews were recorded, transcribed and thematically coded. RESULTS: The analysis yielded four main themes: Current Practice, Future Practice, Changing Culture, and Collaboration. Most of the prescribers interviewed do not currently add RFU to prescriptions. Prescribers were open to sharing RFU with colleagues via a regional database but wanted the ability to provide context for the prescribed medication within the system. Many prescribers were wary of the impact of adding RFU on their workflow but felt it could save time by avoiding clarifying questions from pharmacists. Increased interprofessional collaboration, increased patient understanding of prescribed medications, avoiding guesswork when determining indications and decreased misinterpretation regarding RFU were cited by most prescribers as benefits to including RFU information. CONCLUSIONS: Prescribers were generally open to sharing RFU and clearly identified the benefits to pharmacists and patients if added. Critically, they also identified benefits to their own practices. These results can be used to guide the implementation of future initiatives to promote the sharing of RFU in healthcare teams. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-021-06103-1. BioMed Central 2021-01-26 /pmc/articles/PMC7836591/ /pubmed/33499869 http://dx.doi.org/10.1186/s12913-021-06103-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Whaley, Colin Bancsi, Ashley Ho, Joanne Man-Wai Burns, Catherine M. Grindrod, Kelly Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis |
title | Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis |
title_full | Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis |
title_fullStr | Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis |
title_full_unstemmed | Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis |
title_short | Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis |
title_sort | prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836591/ https://www.ncbi.nlm.nih.gov/pubmed/33499869 http://dx.doi.org/10.1186/s12913-021-06103-1 |
work_keys_str_mv | AT whaleycolin prescribersperspectivesonincludingreasonforuseinformationonprescriptionsandmedicationlabelsaqualitativethematicanalysis AT bancsiashley prescribersperspectivesonincludingreasonforuseinformationonprescriptionsandmedicationlabelsaqualitativethematicanalysis AT hojoannemanwai prescribersperspectivesonincludingreasonforuseinformationonprescriptionsandmedicationlabelsaqualitativethematicanalysis AT burnscatherinem prescribersperspectivesonincludingreasonforuseinformationonprescriptionsandmedicationlabelsaqualitativethematicanalysis AT grindrodkelly prescribersperspectivesonincludingreasonforuseinformationonprescriptionsandmedicationlabelsaqualitativethematicanalysis |